☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
COVID-19 Vaccine
GSK and SK Bioscience Initiate P-III Study of GBP510 Against AZ/Oxford's COVID-19 Vaccine
August 31, 2021
Pfizer and BioNTech's Comirnaty Receive the US FDA's Approval to Prevent COVID-19 in Individuals Aged 16 Years and Older
August 24, 2021
Novavax's COVID-19 Vaccine Demonstrates 90.4% Efficacy in P-III PREVENT-19 Study
June 15, 2021
Pfizer and BioNTech Receive EC's Conditional Marketing Approval for the COVID-19 Vaccine in Adolescents
May 31, 2021
Sanofi and GSK Initiate P-III Clinical Study of their COVID-19 Vaccine
May 27, 2021
Pfizer Initiates Study to Evaluate its Pneumococcal Vaccine with Booster dose of its COVID-19 Vaccine
May 24, 2021
Load more...
Back to Home